Boxer Capital, LLC Dbv Technologies S.A. Transaction History

Boxer Capital, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.54 - $1.05 $135,000 - $262,500	-250,000 Reduced 50.0%	250,000 $200,000
Q4 2023 Feb 14, 2024	SELL	$0.7 - $1.33 $665,000 - $1.26 Million	-950,000 Reduced 65.52%	500,000 $475,000
Q4 2022 Feb 14, 2023	SELL	$1.16 - $1.8 $794,133 - $1.23 Million	-684,598 Reduced 32.07%	1,450,000 $2.22 Million
Q4 2021 Feb 14, 2022	SELL	$1.39 - $5.58 $7.51 Million - $30.1 Million	-5,400,000 Reduced 71.67%	2,134,598 $3.42 Million
Q3 2020 Nov 16, 2020	BUY	$1.58 - $4.77 $790,000 - $2.39 Million	500,000 Added 7.11%	7,534,598 $13 Million
Q1 2020 May 15, 2020	BUY	$2.33 - $12.98 $1.51 Million - $8.44 Million	650,000 Added 10.18%	7,034,598 $27.6 Million
Q4 2019 Feb 14, 2020	BUY	$6.75 - $11.15 $7.32 Million - $12.1 Million	1,084,598 Added 20.46%	6,384,598 $68.3 Million
Q2 2019 Aug 14, 2019	BUY	$7.58 - $10.0 $8.34 Million - $11 Million	1,100,000 Added 26.19%	5,300,000 $43.6 Million
Q1 2019 May 15, 2019	SELL	$5.81 - $9.37 $1.74 Million - $2.81 Million	-300,000 Reduced 6.67%	4,200,000 $32.4 Million
Q4 2018 Feb 14, 2019	BUY	$5.75 - $21.85 $17.3 Million - $65.6 Million	3,000,000 Added 200.0%	4,500,000 $28.9 Million
Q3 2018 Nov 14, 2018	BUY	$16.81 - $24.58 $7.31 Million - $10.7 Million	435,000 Added 40.85%	1,500,000 $33.7 Million
Q2 2018 Aug 14, 2018	BUY	$18.6 - $24.94 $837,000 - $1.12 Million	45,000 Added 4.41%	1,065,000 $20.5 Million
Q1 2018 May 15, 2018	BUY	$20.86 - $26.6 $21.3 Million - $27.1 Million	1,020,000 New	1,020,000 $23.5 Million

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $745M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.